Arkolith/Insider Trading/BDX/Form 4

Feld Michael

EVP, CRO & Pres. Life SciencesBECTON DICKINSON & CO (BDX) · full profile →Form 4 · filed Jan 28, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Sell(S)75$202.73$15K16K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003734) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML